Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
80°
Partly Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biomea Fusion Inc
(NQ:
BMEA
)
7.610
+0.730 (+10.61%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biomea Fusion Inc
< Previous
1
2
3
4
5
6
7
Next >
12 Health Care Stocks Moving In Thursday's After-Market Session
June 06, 2024
Via
Benzinga
Biomea Fusion Announces BMF-219 in Diabetes Placed on Clinical Hold
June 06, 2024
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Short Squeeze Specialists: 3 Stocks With the Expertise to Defy Bearish Expectations
June 06, 2024
Sometimes the bears can push their luck too much, leading to a reverse response. That’s the incentive behind these short squeeze stocks.
Via
InvestorPlace
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
June 03, 2024
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Recap: Biomea Fusion Q4 Earnings
April 01, 2024
Via
Benzinga
What's Going On With Biomea Fusion Stock?
December 11, 2023
Biomea Fusion, Inc. (NASDAQ: BMEA) shares are trading lower Monday.
Via
Benzinga
Biomea Fusion Announces Completion of Enrollment of First 3 Arms in Phase 2 Expansion Cohorts of COVALENT-111 Study for BMF-219 in Type 2 Diabetes
May 30, 2024
BMF-219 is an investigational novel covalent menin inhibitor developed to regenerate insulin-producing beta cells
From
Biomea Fusion, Inc.
Via
GlobeNewswire
BMEA Stock Earnings: Biomea Fusion Misses EPS for Q1 2024
May 02, 2024
BMEA stock results show that Biomea Fusion missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Biomea Fusion Reports First Quarter 2024 Financial Results and Corporate Highlights
May 02, 2024
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 01, 2024
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
April 01, 2024
From
Biomea Fusion, Inc.
Via
GlobeNewswire
BMEA Stock Earnings: Biomea Fusion Misses EPS for Q4 2023
April 01, 2024
BMEA stock results show that Biomea Fusion missed analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Biomea Fusion Highlights Initial Data from the First Two Type 1 Diabetes Patients Dosed with BMF-219
April 01, 2024
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Biomea Fusion Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights
April 01, 2024
From
Biomea Fusion, Inc.
Via
GlobeNewswire
7 Short-Squeeze Stocks That Could Send the Bears Into Panic-Mode
March 07, 2024
Bullish speculators could have their opportunity to blow up the bears with these short-squeeze stocks to buy.
Via
InvestorPlace
Biomea Fusion Presents Patient Cohorts in COVALENT-111 Displaying a Durable Placebo-Adjusted Mean Reduction of up to 1.4% in HbA1c While Off Therapy at Week-26, after BMF-219’s 28-Day Treatment Cycle, Supporting Improved Pancreatic Function
March 06, 2024
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
March 01, 2024
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Feeling Shut Out? 3 Sizzling Stocks and the Pull-Back Prices to Watch For
February 19, 2024
Although FOMO can burn, investors will want to be careful with these stock prices to watch as a little patience can go a long way.
Via
InvestorPlace
3 Speculative Stocks That Could Make Your February Unforgettable
February 18, 2024
Gambling isn’t for everyone. However, if you’re dead set on speculative stocks, these ideas could shift the odds in your favor.
Via
InvestorPlace
3 Long-Term Stocks to Buy on the Dip: February 2024
February 08, 2024
Although these ideas might not be the most exciting in the market, their predictability makes them excellent long-term stocks to buy.
Via
InvestorPlace
Alaska Air Posts Upbeat Earnings, Joins Xerox, United Rentals And Other Big Stocks Moving Higher On Thursday
January 25, 2024
U.S. stocks traded higher, with the Dow Jones gaining around 50 points on Thursday. Shares of Alaska Air Group, Inc. (NYSE: ALK) rose during Thursday’s session following upbeat earnings.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Humana Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
January 25, 2024
Shares of Humana Inc. (NYSE: HUM) fell sharply during Thursday’s session after the company reported fourth-quarter FY23 earnings and issued 2024 guidance.
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
January 10, 2024
Via
Benzinga
Biomea Fusion Highlights Recent Updates and Anticipated 2024 Corporate Milestones at 42nd Annual J.P. Morgan Healthcare Conference
January 09, 2024
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Biomea Fusion Announces Dosing of First Type 1 Diabetes Patient in Phase II Study (COVALENT-112) with BMF-219
January 08, 2024
BMF-219 is an investigational novel covalent menin inhibitor developed to regenerate insulin-producing beta cells with the aim to cure diabetes
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Jim Cramer Says Move On From This Energy Stock: 'It's Moved Too Much'
January 03, 2024
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended moving on from Tidewater Inc. (NYSE: TDW). "It’s moved too much," he added.
Via
Benzinga
Biomea Fusion to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 02, 2024
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Why bluebird bio Shares Are Trading Higher? Here Are Other Stocks Moving In Monday's Mid-Day Session
December 11, 2023
Shares of bluebird bio, Inc. (NASDAQ: BLUE) rose sharply during Monday’s session after the company presented updated data from its gene therapy program in transfusion-dependent beta-thalassemia at the...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
December 11, 2023
Via
Benzinga
Coinbase, Riot Platforms, Marathon Digital And Other Big Stocks Moving Lower On Monday
December 11, 2023
U.S. stocks traded mostly mixed, with the Dow Jones index gaining more than 100 points on Monday. Here are some other big stocks recording losses in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.